VCEL:NASDAQ
Vericel Corp
$56.96
arrow_downward
-0.80%(-0.46) 1D
$56.35
arrow_downward
-1.07% (-0.61)bedtimeAfter hours
Closed: Nov 13, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VCEL...
Open
$57.66
High
$58.42
Low
$56.86
Mkt. cap
2.91B
Avg. vol.
795.66K
Volume
698.79K
P/E ratio
96.98
52-wk high
$59.75
52-wk low
$28.95
EPS
$0.59
Beta
1.08
Shares outstanding
51.03M
No. of employees
398
Open
$57.66
High
$58.42
Low
$56.86
Mkt. cap
2.91B
Avg. vol.
795.66K
Volume
698.79K
P/E ratio
96.98
52-wk high
$59.75
52-wk low
$28.95
EPS
$0.59
Beta
1.08
Shares outstanding
51.03M
No. of employees
398
News stories
From web sources and news partners
www.marketscreener.com
·
13 hours ago
Vericel to Present at the Stephens Annual Investment Conference on Wednesday, November 18, 2026
Yahoo Finance
·
2 days ago
Vericel Corporation (VCEL) Stock Forecasts
Profile
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
In the spring of 2014, Aastrom Bio acquired Sanofi's cell therapy and regenerative medicine business which Sanofi had acquired when purchasing Genzyme in 2011. This transformed Aastrom in several ways: it increased the employee count by 8-fold and provided a revenue stream and products to market, which it had not had before.
In October 2014, the company changed its name from Aastrom Bio to Vericel and relocated its headquarters from Ann Arbor, Michigan to Cambridge, Massachusetts. Wikipedia
About Vericel Corp
CEONick Colangelo
Employees398
Founded1989
HeadquartersCambridge, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Websitevcel.com